Skip to main content

Table 2 Association between total CD4+, CD8+ and Foxp3+CD4+ T cells and clinocopathological characteristics

From: The prognostic influence of tumor infiltrating Foxp3+CD4+, CD4+ and CD8+ T cells in resected non-small cell lung cancer

  Median, (range) CD4+ T cells P Median, (range) CD8+ T cells P Median, (range) Foxp3+CD4+ T cells P
Gender:       
 Female 164 (29–456) NS 195 (68–406) NS 43 (7–88) NS
 Male 209 (27–538) 244 (59–499) 48 (6–92)
Smoking status:       
 Smokers 116 (29–265) <0.05 138 (59–332) <0.05 11 (6–77) NS
 Non-smokers 238 (27–538) 264 (67–499) 52 (6–92)
Histological NSCLC type:       
 Adenocarcinoma 215.5 (116–538) <0.05
<0.05*
284.5 (134–405) NS 56.5 (11–88) NS
 Squamous cell carcinoma 282.5 (119–522) 268.5 (109–499) 57 (16–92)
 Other 176.5 (116–417) 288 (92–361) 45 (13–73)
pT status       
 pT1a-2b 232 (116–538) NS 251 (92–406) NS 57 (11–92) NS
 pT3-4 238 (116–474) 268.5 (137–499) 53 (16–90)
Lymph node status:       
 Negative (N0) 234 (125–522) NS 239 (109–403) NS 57 (11–90) NS
 Positive (N1-N3) 235 (116–538) 270 (92–499) 55 (13–92)
Diferenciation:       
 Poor 253 (116–538) NS 257.5 (109–499) NS 56 (11–92) NS
 Other 212 (116–504) 253 (92–406) 58 (13–88)
COPD:       
 Present 222.5 (116–538) NS 273 (123–405) NS 56 (16–88) NS
 Absent 282 (126–522) 241.5 (92–499) 56.5 (11–92)
  1. *P < 0.05, Mann–Whitney test for difference between adenocarcinoma and squamous cell carcinoma